Dermatofibrosarcoma protuberans |
Histopathological image of dermatofibrosarcoma protuberans. Local recurrence long after the first excision. H&E stain
|
Classification and external resources |
ICD-10 |
C49 (ILDS C49.M24) |
ICD-9-CM |
8832/3 |
ICD-O |
8833/3 |
OMIM |
607907 |
DiseasesDB |
31601 |
eMedicine |
derm/97 |
MeSH |
D018223 |
Dermatofibrosarcoma protuberans (DFSP) [1] is a very rare tumor. It is a rare neoplasm of the dermis layer of the skin,[2] and is classified as a sarcoma. There is only about one case per million per year. DFSP is a fibrosarcoma,[3] more precisely a cutaneous soft tissue sarcoma. In many respects, the disease behaves as a benign tumor, but in 2–5% of cases it can metastasize, so it should be considered to have malignant potential. It occurs most often in adults in their thirties; it has been described congenitally, in children, and the elderly. It accounts for approximately 2–6% of soft tissue sarcoma cancers.
Contents
- 1 Diagnosis
- 2 Presentation
- 3 Pathophysiology
- 4 Treatment
- 5 Additional images
- 6 See also
- 7 References
- 8 External links
Diagnosis
Dermatofibrosarcoma protuberans is diagnosed with a biopsy, when a portion of the tumor is removed for examination. In order to ensure that enough tissue is removed to make an accurate diagnosis, the initial biopsy of a suspected DFSP is usually done with a core needle or a surgical incision.[4]
Presentation
Dermatofibrosarcoma protuberans begins as a minor firm area of skin most commonly about to 1 to 5 cm in diameter. It is a slow growing tumor and is usually found on the torso but can also be found on the arms, legs, head and neck.[5] About 90% of DFSPs are low grade sarcomas. About 10% are mixed; they contain a high-grade sarcomatous component (DFSP-FS); therefore, they are considered to be intermediate-grade sarcomas. DFSPs rarely lead to a metastasis (fewer than 5% do metastasise), but DFSPs can recur locally. DFSPs most often arise in patients who are in their thirties, but sometimes have been described in children or the elderly.
Pathophysiology
More than 90% of DFSP tumors have the chromosomal translocation t(17;22). The translocation fuses the collagen gene (COL1A1) with the platelet-derived growth factor (PDGF) gene. The fibroblast, the cell of origin of this tumor, expresses the fusion gene in the belief that it codes for collagen. However the resulting fusion protein is processed into mature platelet-derived growth factor which is a potent growth factor. Fibroblasts contain the receptor for this growth factor. Thus the cell "thinks" it is producing a structural protein, but it actually produces a self-stimulatory growth signal. The cell divides rapidly and a tumor forms.
The tissue is often positive for CD34.[6][7]
Treatment
Dermatofibrosarcoma protuberans of the left axilla. CT, coronal reconstruction
Treatment is primarily surgical, with chemotherapy and radiation therapy sometimes used.
The NCCN guideline recommends CCPDMA or Mohs surgery[8] for the best cure rate of DFSP. Mohs surgery can be extremely effective. It will remove the tumor and all related pathological cells without a wide-area excision that may overlook sarcoma cells that have penetrated muscle tissue.
The standard of care for patients with DFSP is surgery. Usually, complete surgical resection with margins of 2 to 4 cm (recommended) is performed. The addition of adjuvant radiotherapy (irradiation) improves local control in patients with close or positive margins during the surgery. A special surgical technique, the "Mohs micrographic surgery" (MMS), can be employed in patients with DFSP. MMS is technically possible if the DFSP is in an anatomically confined area. A high probability of cure of DFSP can be attained with MMS as long as the final margins are negative.[9] Patients who have a recurrent DFSP can have further surgery, but the probability of adverse effects of surgery and/or metastasis is increased in these patients. The Mohs surgery is highly successful.
Imatinib is approved for treatment. As is true for all medicinal drugs that have a name that ends in "ib," imatinib is a small molecular pathway inhibitor; imatinib inhibits tyrosine kinase. It may be able to induce tumor regression in patients with recurrent DFSP, unresectable DFSP or metastatic DFSP. There is clinical evidence that imatinib, which inhibits PDGF-receptors, may be effective for tumors positive for the t(17;22) translocation.
Additional images
-
Subcutaneous tissue infiltration (i.e. "honeycomb" growth pattern)
-
Monotonous, plexiform structure of tumour
-
DFSP formed both by fibroblastic and histiocytic elements
-
Hemosiderin deposits beneath the tumour
-
Immunostain positive for CD34
See also
- List of cutaneous conditions
References
- ^ Mendenhall WM, Zlotecki RA, Scarborough MT (December 2004). "Dermatofibrosarcoma protuberans". Cancer 101 (11): 2503–8. doi:10.1002/cncr.20678. PMID 15503305. Review.
- ^ "Dorlands Medical Dictionary:dermatofibrosarcoma".
- ^ "dermatofibrosarcoma" at Dorland's Medical Dictionary
- ^ "What is Dermatofibrosarcoma Protuberans?".
- ^ "Dermatofibrosarcoma protuberans".
- ^ Sirvent N, Maire G, Pedeutour F (May 2003). "Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment". Genes Chromosomes Cancer 37 (1): 1–19. doi:10.1002/gcc.10202. PMID 12661001.
- ^ Patel KU, Szabo SS, Hernandez VS et al. (February 2008). "Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays". Hum. Pathol. 39 (2): 184–93. doi:10.1016/j.humpath.2007.06.009. PMID 17950782.
- ^ http://wwwu.tsgh.ndmctsgh.edu.tw/commcpc/images/nccn/dfsp%20NCCN%202004.pdf
- ^ Gloster HM, Harris KR, Roenigk RK (July 1996). "A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans". J Am Acad Dermatol. 35 (1): 82–7. PMID 8682970.
External links
- humpath #346 (Pathology images)
- Dermatofibrosarcoma Protuberans in the Sarcoma Learning Center
- Thesis on DFSP
Connective/soft tissue tumors and sarcomas (ICD-O 8800–9059) (C45–C49/D17–D21, 171/214–215)
|
|
Not otherwise specified |
- Soft-tissue sarcoma
- Desmoplastic small-round-cell tumor
|
|
Connective tissue neoplasm |
Fibromatous |
Fibroma/fibrosarcoma: |
- Dermatofibrosarcoma protuberans
- Desmoplastic fibroma
|
|
Fibroma/fibromatosis: |
- Aggressive infantile fibromatosis
- Aponeurotic fibroma
- Collagenous fibroma
- Diffuse infantile fibromatosis
- Familial myxovascular fibromas
- Fibroma of tendon sheath
- Fibromatosis colli
- Infantile digital fibromatosis
- Juvenile hyaline fibromatosis
- Plantar fibromatosis
- Pleomorphic fibroma
- Oral submucous fibrosis
|
|
Histiocytoma/histiocytic sarcoma: |
- Benign fibrous histiocytoma
- Malignant fibrous histiocytoma
- Atypical fibroxanthoma
- Solitary fibrous tumor
|
|
|
Myxomatous |
- Myxoma/myxosarcoma
- Cutaneous myxoma
- Superficial acral fibromyxoma
- Angiomyxoma
- Ossifying fibromyxoid tumour
|
|
Fibroepithelial |
- Brenner tumour
- Fibroadenoma
- Phyllodes tumor
|
|
Synovial-like |
- Synovial sarcoma
- Clear-cell sarcoma
|
|
|
Lipomatous |
- Lipoma/liposarcoma
- Myelolipoma
- Myxoid liposarcoma
- PEComa
- Chondroid lipoma
- Intradermal spindle cell lipoma
- Pleomorphic lipoma
- Lipoblastomatosis
- Spindle cell lipoma
- Hibernoma
|
|
Myomatous |
general: |
|
|
smooth muscle: |
|
|
skeletal muscle: |
- Rhabdomyoma/rhabdomyosarcoma: Embryonal rhabdomyosarcoma
- Alveolar rhabdomyosarcoma
|
|
- Leiomyoma
- Angioleiomyoma
- Angiolipoleiomyoma
- Genital leiomyoma
- Leiomyosarcoma
- Multiple cutaneous and uterine leiomyomatosis syndrome
- Multiple cutaneous leiomyoma
- Neural fibrolipoma
- Solitary cutaneous leiomyoma
- STUMP
|
|
|
Complex mixed and stromal |
- Adenomyoma
- Pleomorphic adenoma
- Mixed Müllerian tumor
- Mesoblastic nephroma
- Wilms' tumor
- Malignant rhabdoid tumour
- Clear-cell sarcoma of the kidney
- Hepatoblastoma
- Pancreatoblastoma
- Carcinosarcoma
|
|
Mesothelial |
- Mesothelioma
- Adenomatoid tumor
|
|
Index of muscle
|
|
Description |
- Anatomy
- head
- neck
- arms
- chest and back
- diaphragm
- abdomen
- genital area
- legs
- Muscle tissue
- Physiology
|
|
Disease |
- Myopathy
- Soft tissue
- Connective tissue
- Congenital
- abdomen
- muscular dystrophy
- Neoplasms and cancer
- Injury
- Symptoms and signs
|
|
Treatment |
- Procedures
- Drugs
- anti-inflammatory
- muscle relaxants
|
|
|
Tumors: Skin neoplasm, dermis (C44/D23, 173/216)
|
|
Dermis |
- Benign fibrous histiocytoma/dermatofibrosarcoma protuberans
- Dermatofibrosarcoma protuberans
|
|
Subcutaneous
tumors |
Connective and
vascular |
- see Template:Soft tissue tumors and sarcomas, Template:Vascular tumors, Template:Myeloid malignancy (for mastocytosis)
|
|
Other |
urogenital: |
- Hirsuties coronae glandis
|
|
neuro: |
- Solitary neurofibroma
- Cutaneous meningioma
- Ganglioneuroma
- Schwannoma
- Palisaded encapsulated neuroma
- Infantile neuroblastoma
- Neuroma cutis
|
|
bone/cartilage: |
- Chordoma
- Extraskeletal chondroma
|
|
nevus: |
- Nevus anemicus
- Nevus flammeus
- Nevus flammeus nuchae
- Nevus lipomatosus superficialis
- Nevus oligemicus
- Connective tissue nevus
- Midline nevus flammeus
- Porokeratotic eccrine ostial and dermal duct nevus
|
|
histiocytoma: |
- Pleomorphic undifferentiated sarcoma
- Plexiform fibrohistiocytic tumor
- Progressive nodular histiocytoma
|
|
- Teratoma
- Adenoma sebaceum
- Metastatic carcinoma
- Giant-cell tumor of the tendon sheath
- Glomus tumor
- Granular cell tumor
- Carcinoid
- Desmoid tumor
- Neurothekeoma
- Angiokeratoma
- Zosteriform metastasis
- Keratinizing metaplasia
- Epithelioid sarcoma
|
|
|
|
Index of skin
|
|
Description |
- Anatomy
- Physiology
- Development
|
|
Disease |
- Infections
- Vesiculobullous
- Dermatitis and eczema
- Papulosquamous
- Urticaria and erythema
- Radiation-related
- Pigmentation
- Mucinoses
- Keratosis, ulcer, atrophy, and necrobiosis
- Vasculitis
- Fat
- Neutrophilic and eosinophilic
- Congenital
- Neoplasms and cancer
- nevi and melanomas
- epidermis
- dermis
- Symptoms and signs
- Terminology
|
|
Treatment |
- Procedures
- Drugs
- antibiotics
- disinfectants
- emollients and protectives
- itch
- psoriasis
- other
- Wound and ulcer
|
|
|
Chromosome abnormalities (Q90–Q99, 758)
|
|
Autosomal |
Trisomies |
- Down syndrome
- Edwards syndrome
- Patau syndrome
- Trisomy 9
- Warkany syndrome 2
- Cat eye syndrome/Trisomy 22
- Trisomy 16
|
|
Monosomies/deletions |
- 1q21.1 deletion syndrome/1q21.1 duplication syndrome/TAR syndrome
- Wolf–Hirschhorn syndrome
- Cri du chat/Chromosome 5q deletion syndrome
- Williams syndrome
- Jacobsen syndrome
- Miller–Dieker syndrome/Smith–Magenis syndrome
- DiGeorge syndrome
- 22q11.2 distal deletion syndrome
- 22q13 deletion syndrome
- genomic imprinting
- Angelman syndrome/Prader–Willi syndrome (15)
- Distal 18q-/Proximal 18q-
|
|
|
X/Y linked |
Monosomy |
|
|
Trisomy/tetrasomy,
other karyotypes/mosaics |
- Klinefelter syndrome (47,XXY)
- 48,XXYY
- 48,XXXY
- 49,XXXYY
- 49,XXXXY
- Triple X syndrome (47,XXX)
- 48,XXXX
- 49,XXXXX
|
|
|
Translocations |
Leukemia/lymphoma |
Lymphoid |
- Burkitt's lymphoma t(8 MYC;14 IGH)
- Follicular lymphoma t(14 IGH;18 BCL2)
- Mantle cell lymphoma/Multiple myeloma t(11 CCND1:14 IGH)
- Anaplastic large cell lymphoma t(2 ALK;5 NPM1)
- Acute lymphoblastic leukemia
|
|
Myeloid |
- Philadelphia chromosome t(9 ABL; 22 BCR)
- Acute myeloblastic leukemia with maturation t(8 RUNX1T1;21 RUNX1)
- Acute promyelocytic leukemia t(15 PML,17 RARA)
- Acute megakaryoblastic leukemia t(1 RBM15;22 MKL1)
|
|
|
Other |
- Ewing's sarcoma t(11 FLI1; 22 EWS)
- Synovial sarcoma t(x SYT;18 SSX)
- Dermatofibrosarcoma protuberans t(17 COL1A1;22 PDGFB)
- Myxoid liposarcoma t(12 DDIT3; 16 FUS)
- Desmoplastic small round cell tumor t(11 WT1; 22 EWS)
- Alveolar rhabdomyosarcoma t(2 PAX3; 13 FOXO1) t (1 PAX7; 13 FOXO1)
|
|
|
Other |
- Fragile X syndrome
- Uniparental disomy
- XX male syndrome
- Ring chromosome (13; 14; 15; 20)
|
|
Index of developmental medicine
|
|
Description |
- Embryology
- Cell lines
- endoderm
- mesoderm
- ectoderm
|
|
Disease |
- Due to toxins
- Syndromes
- Chromosomal
- Neonate
- Twins
|
|
|